Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the effect of L-menthol on breathlessness and exercise capacity in patients with Interstitial lung disease (ILD).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Region Skane
Collaborators
NCT07500818 · Interstitial Lung Disease (ILD), Lung Biopsy
NCT06992661 · Interstitial Lung Disease (ILD), Healthy Volunteers
NCT07319598 · Interstitial Lung Disease (ILD), Connective Tissue Disease-associated Interstitial Lung Disease
NCT06615492 · Respiratory Failure, Interstitial Lung Disease (ILD), and more
NCT06911632 · Pulmonary Hypertension, Interstitial Lung Disease (ILD)
Blekinge Institute of Technology
Karlskrona, Blekinge County
Lund University hospital and Region Skåne
Lund
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions